Company intelligence / Profile preview

Silver Bullet Therapeutics

San Jose, California, United States

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Silver Bullet Therapeutics has developed proprietary antimicrobial coatings for orthopedic implants to prevent and treat bone-based infections. Its OrthoFuzIon™ Bone Screw received CE Mark approval in the EU for commercial sale and is undergoing a non-inferiority 510k study in the US. Preclinical and animal studies support reduction of bacterial colonization and biofilm formation. Data published in collaboration with Straumann validate the efficacy of the AgPt (AntiBacterIon) alloy in reducing microbial biofilm.

Therapeutic areas: OtherInfectious DiseasesRheumatology
Modalities: DeviceAntimicrobial coatingSilver ionization coating
Industry: Implantable Medical Devices

Partnerships

Merge MedicalStraumann (R&D relationship)Pitch Sink (startup ecosystem collaboration)

Beyond the preview

Go deeper on Silver Bullet Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silver Bullet Therapeutics.

Explore the full profile